Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas

Clinical trial NCT02228512 · WITHDRAWN

Trial details

NCT number: NCT02228512
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease Primary Effusion Lymphoma

Start date: 2014-08-15
Primary completion: 2015-05-05
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.